Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Shift in MSL1 alternative polyadenylation in response to DNA damage protects cancer cells from chemotherapeutic agent-induced apoptosis

Cell Reports(2021)10.1016/j.celrep.2021.109815Source: DataRank Database

Shift in MSL1 alternative polyadenylation in response to DNA damage protects cancer cells from chemotherapeutic agent-induced apoptosis is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

Linked data & code

geo cellosaurus hpa

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: goldTopics (39)IDs (PubMed, PMC)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Vivian I. Anyaeche ORCID,R. Samuel Herron ORCID,Christopher Y. Park ORCID,Hun‐Way Hwang ORCID,Alexander K. Kunisky ORCID

Live enrichment

PubMed:34644577 PMC:PMC8580136

National Institute of Neurological Disorders and Stroke

Grant: NS113861

NINDS NIH HHS

Grant: T32 NS007433

NINDS NIH HHS

Grant: R01 NS113861

National Institutes of Health

Grant: 5R01NS113861-03

Regulation and biological functions of mRNA Alternative Polyadenylation in the Brain

National Institutes of Health

University of Pittsburgh

Université Pierre et Marie Curie

goldLicense: cc-by-nc-nd

publisherhttp://www.cell.com/article/S2211124721012791/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124721012791?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124721012791?httpAccept=text/plain

repositoryhttp://europepmc.org/pmc/articles/PMC8580136

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8580136

Fields of Study

0301 basic medicine03 medical and health sciences

MeSH Terms

HCT116 CellsHela CellsHumansNeoplasmsDNA DamageDoxorubicinmRNA Cleavage and Polyadenylation FactorsAntibiotics, AntineoplasticSignal TransductionApoptosisGene Expression Regulation, NeoplasticPolyadenylationDrug Resistance, NeoplasmHistone Acetyltransferases

Keywords

ApoptosisDNA damageCancerp53RNA processingCisplatinChemotherapyAlternative PolyadenylationMslPcf11mRNA Cleavage and Polyadenylation FactorsAntibiotics, AntineoplasticHCT116 CellsPolyadenylationArticleGene Expression Regulation, NeoplasticDoxorubicinDrug Resistance, NeoplasmNeoplasmsHumansHeLa CellsHistone AcetyltransferasesSignal Transduction

Sustainable Development Goals

SDG 3: 3. Good health